LivaNova PLC logo

LivaNova PLC (LIVN)

Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
80. 70
-1.09
-1.3327%
$
4.54B Market Cap
164.88 P/E Ratio
- Div Yield
445,700 Volume
3 Eps
$ 81.79
Previous Close
Add Transaction
Day Range
79.96 82.04
Year Range
41.01 85.27
Want to track LIVN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
LivaNova PLC (LIVN) Hit a 52 Week High, Can the Run Continue?

LivaNova PLC (LIVN) Hit a 52 Week High, Can the Run Continue?

LivaNova (LIVN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks | 1 week ago
LivaNova Reports Improved OSA Outcomes With PolySync Programming

LivaNova Reports Improved OSA Outcomes With PolySync Programming

LIVN's PolySync data show an 84.5% AHI response rate in OSA patients, building on OSPREY results for its aura6000 System.

Zacks | 1 month ago
LivaNova PLC (LIVN) Shareholder/Analyst Call Prepared Remarks Transcript

LivaNova PLC (LIVN) Shareholder/Analyst Call Prepared Remarks Transcript

LivaNova PLC (LIVN) Shareholder/Analyst Call Prepared Remarks Transcript

Seekingalpha | 1 month ago
LivaNova PLC (LIVN) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

LivaNova PLC (LIVN) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

LivaNova PLC (LIVN) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Seekingalpha | 1 month ago
LivaNova (LIVN) Upgraded to Buy: Here's What You Should Know

LivaNova (LIVN) Upgraded to Buy: Here's What You Should Know

LivaNova (LIVN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks | 2 months ago
LivaNova PLC (LIVN) Q1 2026 Earnings Call Transcript

LivaNova PLC (LIVN) Q1 2026 Earnings Call Transcript

LivaNova PLC (LIVN) Q1 2026 Earnings Call Transcript

Seekingalpha | 2 months ago
LivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates

LivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates

LivaNova (LIVN) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.85 per share. This compares to earnings of $0.88 per share a year ago.

Zacks | 2 months ago
LivaNova Expands OSA Care With FDA-Approved aura6000 System

LivaNova Expands OSA Care With FDA-Approved aura6000 System

LIVN wins FDA nod for its aura6000 sleep apnea system, marking a pivotal step in neurostimulation with strong trial results and new growth potential.

Zacks | 3 months ago
Down 7.2% in 4 Weeks, Here's Why You Should You Buy the Dip in LivaNova (LIVN)

Down 7.2% in 4 Weeks, Here's Why You Should You Buy the Dip in LivaNova (LIVN)

The heavy selling pressure might have exhausted for LivaNova (LIVN) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Zacks | 4 months ago
All You Need to Know About LivaNova (LIVN) Rating Upgrade to Buy

All You Need to Know About LivaNova (LIVN) Rating Upgrade to Buy

LivaNova (LIVN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks | 4 months ago
LivaNova PLC (LIVN) Q4 2025 Earnings Call Transcript

LivaNova PLC (LIVN) Q4 2025 Earnings Call Transcript

LivaNova PLC (LIVN) Q4 2025 Earnings Call Transcript

Seekingalpha | 4 months ago
LivaNova (LIVN) Reports Q4 Earnings: What Key Metrics Have to Say

LivaNova (LIVN) Reports Q4 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for LivaNova (LIVN) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks | 4 months ago
Loading...
Load More